Chronic Lung Disease of Prematurity Completed Phase 2 Trials for Hydrocortisone (DB00741)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00167544Randomized Trial of Hydrocortisone in Very Preterm High-Risk InfantsPrevention
NCT00004669Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary DysplasiaPrevention